References:
  1. Otto, C. M., et al. (2021). ”2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Circulation 143(5): e72-e22
  2. Alavi SH, Groves EM, Kheradvar A. The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg 2014; 97:1260–6.
  3. Doff B. McElhinney, Jamil A. Aboulhosn, et al., Mid-Term Valve-Related Outcomes After Transcatheter Tricuspid Valve-in-Valve or Valve-in-Ring Replacement, Journal of the American College of Cardiology
  4. Yoon S-H, Whisenant BK, Bleiziffer S, et al.Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019; 40:441–51
  5. Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 2015;8: e001779
  6. A.C. Egbe, S.V. Pislaru, P.A. Pellikka, et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors J Am Coll Cardiol, 66 (2015), pp. 2285-2294
  7. Rishi Puri, Vincent Auffret, Josep Rodés-Cabau, Bioprosthetic Valve Thrombosis, Journal of the American College of Cardiology, Volume 69, Issue 17,2017,pp 2193-2211,
  8. Adi Butnaru, Joseph Shaheen, et al. Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Rev Esp Cardiol (Engl Ed) 2015; 68:198–204.
  9. Jose J, Sulimov DS, et al. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. JACC Cardiovasc Interv. 2017 Apr 10;10(7):686-697. doi: 10.1016/j.jcin.2017.01.045. PMID: 28385406.
  10. Marwan M, Mekkhala N, Göller M, Röther J, Bittner D, Schuhbaeck A, Hell M, Muschiol G, Kolwelter J, Feyrer R, Schlundt C, Achenbach S, Arnold M. Leaflet thrombosis following transcatheter aortic valve implantation. J Cardiovasc Comput Tomogr. 2018 Jan-Feb;12(1):8-13. doi: 10.1016/j.jcct.2017.11.002. Epub 2017 Nov 9. PMID: 29195844.
  11. Maryam Shojaeifard, Negar Sarrafirad, Sajad Erami, et al. Management and Clinical Outcomes in Patients with Mechanical Tricuspid Valve Thrombosis. Authorea. June 08, 2020.
  12. Özkan, M., et al. (2013). ”Comparison of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis.” JACC: Cardiovascular Imaging 6(2): 206-216.
  13. Nathem Akhras, Hani Al Sergani, et al. Thrombolytic Therapy as the Management of Mitral Transcatheter Valve-in-Valve Implantation Early Thrombosis, Heart, Lung and Circulation, Volume 25, Issue 5, 2016
  14. Özkan M, Gündüz S, et al., Ultraslow thrombolytic therapy: A novel strategy in the management of Prosthetic Mechanical valve Thrombosis and the predictors of outcome: The Ultra-slow PROMETEE trial. Am Heart J. 2015 Aug;170(2):409-18. doi: 10.1016/j.ahj.2015.04.025.